Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 12 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BORTEZOMIB | [2] Bortezomib Bortezomib (Bortezomib Accord),Bortezomib D-mannitol (PMS-bortezomib) | [1] Bortezomib
Bortezomib
(Bortezomib) 💬1. BORTEZOMIB
| [1] PSMB5 PSMB5 💬1. BORTEZOMIB
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | [17] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬1. BORTEZOMIB
| ||||||||||||||||||||||||||||||||||||||||||||
| 2 | Bortezomib (Velcade®) | [1] Bortezomib Bortezomib (Bortezomib Accord) | [1] Bortezomib
Bortezomib
(Bortezomib) 💬2. Bortezomib (Velcade®)
| [1] PSMB5 PSMB5 💬2. Bortezomib (Velcade®)
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | [1] 66 66 💬2. Bortezomib (Velcade®)
| ||||||||||||||||||||||||||||||||||||||||||||
| 3 | Bortezomib Accord | [2] Bortezomib Bortezomib (Bortezomib Accord),Bortezomib D-mannitol (PMS-bortezomib) | [1] Bortezomib
Bortezomib
(Bortezomib) 💬3. Bortezomib Accord
| [1] PSMB5 PSMB5 💬3. Bortezomib Accord
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | [1] 28 28 💬3. Bortezomib Accord
| ||||||||||||||||||||||||||||||||||||||||||||
| 4 | Bortezomib D-mannitol | [3] Bortezomib Bortezomib (Bortezomib Accord),Bortezomib D-mannitol (PMS-bortezomib), Mannitol | [2] Mannitol
Mannitol
,Bortezomib (Bortezomib) 💬 4. Bortezomib D-mannitol
| [1] PSMB5 PSMB5 💬4. Bortezomib D-mannitol
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | [1] 28 28 💬4. Bortezomib D-mannitol
| ||||||||||||||||||||||||||||||||||||||||||||
| 5 | Bortezomib Injection | [1] Bortezomib Bortezomib (Bortezomib Accord) | [1] Bortezomib
Bortezomib
(Bortezomib) 💬5. Bortezomib Injection
| [1] PSMB5 PSMB5 💬5. Bortezomib Injection
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | [1] 64 64 💬5. Bortezomib Injection
| ||||||||||||||||||||||||||||||||||||||||||||
| 6 | Bortezomib/dexamethasone | [2] Bortezomib Bortezomib (Bortezomib Accord),Dexamethasone | [2] Dexamethasone
Dexamethasone
,Bortezomib (Bortezomib) 💬 6. Bortezomib/dexamethasone
| [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | [1] 283 283 💬6. Bortezomib/dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||
| 7 | Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone | [2] Bortezomib Bortezomib (Bortezomib Accord),Dexamethasone | [2] Dexamethasone
Dexamethasone
,Bortezomib (Bortezomib) 💬 7. Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
| [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | [1] 28 28 💬7. Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||
| 8 | Combination of a single dose anti-CD20 antibody and bortezomib | [1] Bortezomib Bortezomib (Bortezomib Accord) | [1] Bortezomib
Bortezomib
(Bortezomib) 💬8. Combination of a single dose anti-CD20 antibody and bortezomib
| [1] PSMB5 PSMB5 💬8. Combination of a single dose anti-CD20 antibody and bortezomib
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | [1] 61 61 💬8. Combination of a single dose anti-CD20 antibody and bortezomib
| ||||||||||||||||||||||||||||||||||||||||||||
| 9 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen | [3] Bortezomib Bortezomib (Bortezomib Accord),Cyclophosphamide, Dexamethasone | [4] Cyclophosphamide
Cyclophosphamide
,Dexamethasone , Bortezomib (Bortezomib), Cyclophosphamide 💬 9. Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
| [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | [1] 28 28 💬9. Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
| ||||||||||||||||||||||||||||||||||||||||||||
| 10 | Cyclophosphamide, Bortezomib, dexamethasone | [3] Bortezomib Bortezomib (Bortezomib Accord),Cyclophosphamide, Dexamethasone | [4] Cyclophosphamide
Cyclophosphamide
,Dexamethasone , Bortezomib (Bortezomib), Cyclophosphamide 💬 10. Cyclophosphamide, Bortezomib, dexamethasone
| [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | [1] 28 28 💬10. Cyclophosphamide, Bortezomib, dexamethasone
|